Controversies on the prevention of insulin-dependent diabetes mellitus by immunomodulation: lessons from NOD mice treated with beta-1,6;1,3-D-glucan and rhIGF-I.
Kida
K
K
Department of Pediatrics, Ehime University School of Medicine, Japan.
Kaino
Y
Y
Ito
T
T
Hirai
H
H
D000276:Adjuvants, Immunologic / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D000595:Amino Acid Sequence; D000818:Animals; D001786:Blood Glucose / Q000187:drug effects; D003922:Diabetes Mellitus, Type 1 / Q000517:prevention & control* / Q000628:therapy; D004195:Disease Models, Animal; D005260:Female; D005936:Glucans / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D007328:Insulin / Q000737:chemistry; D007334:Insulin-Like Growth Factor I / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D051379:Mice; D016688:Mice, Inbred NOD; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000737:chemistry; D011897:Random Allocation; D011994:Recombinant Proteins / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D013154:Spleen / Q000166:cytology / Q000187:drug effects; D013223:Statistics as Topic; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D000276:Adjuvants, Immunologic; D001786:Blood Glucose; D005936:Glucans; D007328:Insulin; D010446:Peptide Fragments; D011994:Recombinant Proteins; C033671:epiglucan; C097877:insulin B (9-23); D007334:Insulin-Like Growth Factor I